Article Text

Download PDFPDF
Sudden cardiac death: opportunities for prevention


The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current guidance/guidelines, explain the evidence base, and suggest a UK ICD implantation strategy

  • ATP, antitachycardia pacing
  • AVID, antiarrhythmics versus implantable defibrillators study
  • CABG Patch, coronary artery bypass graft patch trial
  • CARE-HF, cardiac resynchronization-heart failure study
  • CASH, cardiac arrest study Hamburg
  • CIDS, Canadian implantable defibrillator study
  • CRT, cardiac resynchronisation therapy
  • DAVID, dual chamber and VVI implantable defibrillator trial
  • DINAMIT, defibrillator in acute myocardial infarction trial
  • EF, ejection fraction
  • EPS, electrophysiological study
  • ICD, implantable cardioverter-defibrillator
  • MADIT I, multicenter automatic defibrillator implantation trial
  • MADIT II, multicenter automatic defibrillator implantation trial II
  • MI, myocardial infarction
  • MUSTT, multicenter unsustained tachycardia trial
  • NHS, National Health Service
  • NICE, National Institute for Health and Clinical Excellence
  • NYHA, New York Heart Association
  • QoL, quality of life
  • SCD, sudden cardiac death
  • SCD HeFT, sudden cardiac death in heart failure trial
  • VF, ventricular fibrillation
  • VT, ventricular tachycardia
  • cost efficacy
  • implantable cardioverter-defibrillator
  • ICD
  • guidelines
  • sudden cardiac death

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.